Differentiation-inducing triiodothyronine enhances chemotherapy and suppresses post-treatment tumor regrowth in medulloblastoma.

Saved in:
Bibliographic Details
Title: Differentiation-inducing triiodothyronine enhances chemotherapy and suppresses post-treatment tumor regrowth in medulloblastoma.
Authors: Yang Y; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA., Ronsley R; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy, Department of Pediatrics, Seattle Children's Hospital and the University of Washington.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kilburn L; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC 20816, USA., Kim A; Department of Medical Engineering, University of South Florida, Tampa, FL 33620, USA., Wechsler-Reya RJ; Department of Neurology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA., Yang ZJ; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA.
Source: Molecular therapy. Oncology [Mol Ther Oncol] 2026 May 14; Vol. 34 (2), pp. 201235. Date of Electronic Publication: 2026 May 14 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2950-3299
DOI:10.1016/j.omton.2026.201235